These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30575647)

  • 21. The gut microbiota as a novel regulator of cardiovascular function and disease.
    Battson ML; Lee DM; Weir TL; Gentile CL
    J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota in kidney disease and hypertension.
    Antza C; Stabouli S; Kotsis V
    Pharmacol Res; 2018 Apr; 130():198-203. PubMed ID: 29496593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salt and Gut Microbiota in Heart Failure.
    Masenga SK; Kirabo A
    Curr Hypertens Rep; 2023 Aug; 25(8):173-184. PubMed ID: 37219766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unveiling the relationship between gut microbiota and heart failure: Recent understandings and insights.
    Jain H; Marsool MDM; Goyal A; Sulaiman SA; Fatima L; Idrees M; Sharma B; Borra V; Gupta P; Nadeem A; Jain J; Ali H; Sohail AH
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102179. PubMed ID: 37923029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in cardiovascular disease.
    Lezutekong JN; Nikhanj A; Oudit GY
    Clin Sci (Lond); 2018 Apr; 132(8):901-904. PubMed ID: 29712884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut Dysbiosis in Animals Due to Environmental Chemical Exposures.
    Rosenfeld CS
    Front Cell Infect Microbiol; 2017; 7():396. PubMed ID: 28936425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The gut-immune axis during hypertension and cardiovascular diseases.
    Dinakis E; O'Donnell JA; Marques FZ
    Acta Physiol (Oxf); 2024 Aug; 240(8):e14193. PubMed ID: 38899764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carotenoid supplementation and retinoic acid in immunoglobulin A regulation of the gut microbiota dysbiosis.
    Lyu Y; Wu L; Wang F; Shen X; Lin D
    Exp Biol Med (Maywood); 2018 Apr; 243(7):613-620. PubMed ID: 29534601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the gut microbiome in sex differences in arterial pressure.
    Beale AL; Kaye DM; Marques FZ
    Biol Sex Differ; 2019 Apr; 10(1):22. PubMed ID: 31023366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases.
    Schiattarella GG; Sannino A; Esposito G; Perrino C
    Trends Cardiovasc Med; 2019 Apr; 29(3):141-147. PubMed ID: 30126689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Review of the relation between gut microbiome, metabolic disease and hypertension].
    Barna I; Nyúl D; Szentes T; Schwab R
    Orv Hetil; 2018 Mar; 159(9):346-351. PubMed ID: 29480046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.
    Bandera A; De Benedetto I; Bozzi G; Gori A
    Curr Opin HIV AIDS; 2018 Jan; 13(1):73-80. PubMed ID: 29045252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Gut Microbiome, Energy Homeostasis, and Implications for Hypertension.
    Riedl RA; Atkinson SN; Burnett CML; Grobe JL; Kirby JR
    Curr Hypertens Rep; 2017 Apr; 19(4):27. PubMed ID: 28316052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.
    Nagatomo Y; Tang WH
    J Card Fail; 2015 Dec; 21(12):973-80. PubMed ID: 26435097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible Role of Gut Microbiota Alterations in Myocardial Fibrosis and Burden of Heart Failure in Hypertensive Heart Disease.
    Pitt B; Diez J
    Hypertension; 2024 Jul; 81(7):1467-1476. PubMed ID: 38716665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteobacteria: microbial signature of dysbiosis in gut microbiota.
    Shin NR; Whon TW; Bae JW
    Trends Biotechnol; 2015 Sep; 33(9):496-503. PubMed ID: 26210164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between gut microbiome and cardiovascular disease.
    Peng J; Xiao X; Hu M; Zhang X
    Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.